The Latest Breaking News from the 5th Circuit

Mifepristone will remain on the market for now with no changes to how it can be prescribed.

The legal challenge to mifepristone now returns to the 5th U.S. Circuit Court of Appeals in New Orleans.

An early April 2023 decision by a U.S. district judge in Texas to reverse 23 years of approval of the abortion pill mifepristone has sparked explosive debate.

WASHINGTON — The Justice Department and a pharmaceutical company on Friday asked the Supreme Court to intervene in the court fight over a commonly used abortion drug in order to keep a court ruling restricting availability of the drug from taking effect this weekend.

Government says restrictions on mifepristone would deny people ‘lawful access’ to drug deemed safe by US regulators.

The ruling comes after a federal judge in Texas suspended the FDA's 2000 approval of mifespristone, a drug used for medication abortions.

It’s not the FDA’s job to tell doctors what to do.

WASHINGTON — Attorney General Merrick Garland said the Biden administration will ask the U.S. Supreme Court to protect the availability of a widely used abortion pill after a federal appeals court cleared the way for new restrictions to take effect Friday.

WASHINGTON — A Louisiana-based federal appeals court could decide as soon as Wednesday the availability of the nation’s most used medication abortion drug, as members of Congress from both parties weighed in on a lower court ruling that would stop the manufacture and distribution of the drug this Saturday.